Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study
about
Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeuticsRoads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine PathologyStress-Related Immune Markers in Depression: Implications for TreatmentGlucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunctionA neuropeptide Y variant (rs16139) associated with major depressive disorder in replicate samples from Chinese Han population.Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions.A new paradigm in sweat based wearable diagnostics biosensors using Room Temperature Ionic Liquids (RTILs).Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene × environment interactions.Evaluation of stress systems by applying noninvasive methodologies: measurements of neuroimmune biomarkers in the sweat, heart rate variability and salivary cortisol.Neuroendocrine and immune contributors to fatigueThe microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implicationsArtificial microfluidic skin for in vitro perspiration simulation and testing.Effects of a skin neuropeptide (substance p) on cutaneous microflora.Calcitonin gene-related peptide and menopauseMajor depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions.Socioeconomic status, race, and bone turnover in the Midlife in the US Study.Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) stuCaregiving burden, stress, and health effects among family caregivers of adult cancer patients.Calcitonin gene-related peptide pre-administration acts as a novel antidepressant in stressed miceGestational environment programs adult depression-like behavior through methylation of the calcitonin gene-related peptide gene.The skin function: a factor of anti-metabolic syndromeEffect of Substance P in Staphylococcus aureus and Staphylococcus epidermidis Virulence: Implication for Skin HomeostasisInflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.Holistic Care in the US Military I-The Epidaurus Project: An Initiative in Holistic Medicine for the Military Health System, 2001-2012.Skin-bacteria communication: Involvement of the neurohormone Calcitonin Gene Related Peptide (CGRP) in the regulation of Staphylococcus epidermidis virulence.Depression as a risk factor for osteoporosis.Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study.Substance P and Calcitonin Gene-Related Peptide: Key Regulators of Cutaneous Microbiota HomeostasisAlterations in splenic function and gene expression in mice with depressive-like behavior induced by exposure to corticosterone.Cytokines and depression: findings, issues, and treatment implications.Blood-based biomarkers in depression: emerging themes in clinical research.Advanced Materials for Health Monitoring with Skin-Based Wearable Devices.Using sweat to measure cytokines in older adults compared to younger adults: A pilot study.Exposure to Ambient Air Particles Increases the Risk of Mental Disorder: Findings from a Natural Experiment in Beijing.Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis.Seeking an objective diagnosis of depression.Expression levels of neuroimmune biomarkers in hypothalamus of allergic mice after phthalate exposure.Expression of tachykinins and their receptors in plaque psoriasis with pruritus.Advanced Metrics for Assessing Holistic Care: The "Epidaurus 2" Project.
P2860
Q24618470-A7F7B337-EEC3-4731-9965-9F8627215D18Q26752538-A4AA36E3-F66F-4CF5-880B-F6F4A891D566Q26771607-8132C061-2610-4EC9-A5CD-894FA81061BEQ27024383-7D224D2F-2EB3-45F6-A6FB-48B84BC37B49Q30457617-EC81EFC3-FB57-49B1-A1E8-384145D9F598Q30462675-4A83C6F7-4513-4771-B60D-290EECB7D59CQ33679060-36BACF76-71C6-4689-BBAC-F33C7124EAE2Q33694712-0F09D351-CF1A-4EB0-AC40-4E8E1EA8B2B2Q33998969-F84228B5-DD01-46CD-8BEB-8A53A2A5D794Q34051029-C53F1981-6FA3-4DE9-B098-8D41186503C4Q34103068-6A5FA1A9-EB80-41CC-98D5-62D68F9800ABQ34479402-8652DD16-5272-44EB-AD22-95E4F9794ABEQ34663203-3B2169CD-A9C2-415A-B0F6-F281D53542BEQ35046639-4E0A42E6-5FB1-4BF8-A608-EFD72D6955DEQ35114148-CA11EEEB-8B9C-471C-B115-6FD906E45875Q35237253-02B858C4-016D-4C2E-9AE9-1C9EBAD1C352Q35670217-37315BFD-78BF-4A58-BC5F-B17D134E7197Q35749948-C05C5BD9-26F8-4642-AB60-B2F1545E581DQ35832813-9ABED103-4904-45B6-AF5E-55F1BFFE9743Q35926129-86792CAC-928F-478D-A5EA-199FB2F60BADQ36527496-C57D4690-12F0-437A-AA13-5C8A8B6D6B2AQ36595629-DCE0A327-12F8-46FD-8C7A-0BD7E48F71F9Q36799709-3B56CAD7-9B72-4AFA-B5FB-D368F4E1EB40Q37047749-091B6CDD-6BC5-49DE-869E-3F0B2DCFE53AQ37323831-95243F66-F89B-4CBB-9FB9-E9D405D87FFAQ37339855-5E560BA6-00E8-498E-BD61-B5255B48FBE5Q37393313-7B4ACD16-81F8-45FC-927A-233948C185EEQ37435408-7B9F4E27-EB72-4D8C-AF0C-8A57E64D1BB9Q37611804-2300D46C-A88D-4BBB-85BF-EFFE42AE0028Q37711960-B5232F7E-26FF-4EED-A099-3CC8C5FA75AFQ37884614-1821B6E0-8BB6-4244-B294-FC4554368108Q38219783-78A4E47E-BE98-430A-A48E-80918ADA2B62Q39216568-A46FAD65-D2F0-4915-B448-0120DA14B719Q47219990-2C0BA3E6-6A69-4BAE-B57F-A33C31128B58Q47554071-DB0A92F6-7320-4327-BEAB-F9B31F752822Q47709549-CF16DDCE-A3FF-449D-889A-471D79E62E02Q48048867-9BB0D687-67C3-42C6-BB58-8D9101D69E24Q48297514-C0BB0EF3-373E-4622-9AA7-2163648C965DQ48916472-F5379463-D092-4B14-A27C-9053E66E3374Q50421236-6E149C05-614E-4E3A-B0C8-1F81204E7ABC
P2860
Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated neuroimmune biomarker ...... in remission: the POWER study
@en
Elevated neuroimmune biomarker ...... in remission: the POWER study.
@nl
type
label
Elevated neuroimmune biomarker ...... in remission: the POWER study
@en
Elevated neuroimmune biomarker ...... in remission: the POWER study.
@nl
prefLabel
Elevated neuroimmune biomarker ...... in remission: the POWER study
@en
Elevated neuroimmune biomarker ...... in remission: the POWER study.
@nl
P2093
P2860
P1476
Elevated neuroimmune biomarker ...... in remission: the POWER study
@en
P2093
Andrea H Marques
Esther M Sternberg
Farideh Eskandari
Giovanni Cizza
Israel C Christie
Marni N Silverman
POWER Study Group
Sara Torvik
Terry M Phillips
P2860
P304
P356
10.1016/J.BIOPSYCH.2008.05.035
P407
P577
2008-07-26T00:00:00Z